Longeveron(LGVN) - 2023 Q3 - Earnings Call Presentation

ASRM approval can lead to revenue generation years before BLA application with FDA or conditional approval by PMDA Clinical Trial in Japan (N=45) ‒ NCGG (Nagoya) and Juntendo University (Tokyo) selected as clinical sites *Frailty/Aging-Related Frailty" presently does not have a consensus definition of the indication for regulatory purposes; however, it is likely that safety as observed in the proposed Phase 2 trial in Japan combined with the US Frailty 2b study will result in ASRM approval • Previous therap ...